
Criteo SA
NASDAQ:CRTO

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
23.48
49.66
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
CRTO
stock under the Base Case scenario is
59.67
USD.
Compared to the current market price of 23.68 USD,
Criteo SA
is
Undervalued by 60%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Criteo SA
Historical valuation for CRTO cannot be conducted due to limitations such as insufficient data or other constraints.
FR |
![]() |
Publicis Groupe SA
PAR:PUB
|
|
UK |
![]() |
Informa PLC
LSE:INF
|
|
US |
![]() |
Omnicom Group Inc
NYSE:OMC
|
|
CN |
F
|
Focus Media Information Technology Co Ltd
SZSE:002027
|
|
US |
![]() |
Interpublic Group of Companies Inc
NYSE:IPG
|
|
UK |
![]() |
WPP PLC
LSE:WPP
|
|
JP |
![]() |
Dentsu Group Inc
TSE:4324
|
|
JP |
![]() |
CyberAgent Inc
TSE:4751
|
|
JP |
![]() |
GMO AD Partners Inc
TSE:4784
|
|
FR |
![]() |
JCDecaux SA
OTC:JCDXF
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Criteo SA
Balance Sheet Decomposition
Criteo SA
Current Assets | 1.1B |
Cash & Short-Term Investments | 313.2m |
Receivables | 716.1m |
Other Current Assets | 54.7m |
Non-Current Assets | 1B |
Long-Term Investments | 21.1m |
PP&E | 206.4m |
Intangibles | 681.4m |
Other Non-Current Assets | 135.1m |
Current Liabilities | 886.8m |
Accounts Payable | 641.4m |
Accrued Liabilities | 144.1m |
Other Current Liabilities | 101.3m |
Non-Current Liabilities | 176.5m |
Long-Term Debt | 309k |
Other Non-Current Liabilities | 176.2m |
Free Cash Flow Analysis
Criteo SA
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Criteo SA
Revenue
|
1.9B
USD
|
Cost of Revenue
|
-931.9m
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-813.5m
USD
|
Operating Income
|
189.2m
USD
|
Other Expenses
|
-47m
USD
|
Net Income
|
142.3m
USD
|
CRTO Profitability Score
Profitability Due Diligence
Criteo SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Criteo SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CRTO Solvency Score
Solvency Due Diligence
Criteo SA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Score
Criteo SA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRTO Price Targets Summary
Criteo SA
According to Wall Street analysts, the average 1-year price target for
CRTO
is 42.93 USD
with a low forecast of 30.3 USD and a high forecast of 56.7 USD.
Dividends
Current shareholder yield for CRTO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRTO
stock under the Base Case scenario is
59.67
USD.
Compared to the current market price of 23.68 USD,
Criteo SA
is
Undervalued by 60%.